分享好友 环球市场首页 环球市场分类 切换频道

Nasal Cannula Market

2024-04-3000

Market Overview

The Global Nasal Cannula Market size is expected to be worth around USD 14.6 Billion by 2033, from USD 7.9 Billion in 2023, growing at a CAGR of 6.3% during the forecast period from 2024 to 2033.

A nasal cannula is a medical device used to deliver supplemental oxygen or increased airflow to individuals who have difficulty breathing due to a medical condition or another reason. It is a thin, flexible tube that wraps around the head, with two prongs that go inside the nostrils to deliver the oxygen.

The other end of the tube is connected to an oxygen supply, such as a tank or a portable oxygen generator. Nasal cannulas are often used in patients with conditions such as COPD, and they are suitable for individuals who require small amounts of supplemental oxygen without rigid control of respiration, such as in oxygen therapy.

The rise in the prevalence of respiratory disease worldwide is a major factor that has contributed to the market’s growth. About 41% of all chronic respiratory diseases were responsible for the increase in morbidity, with asthma and COPD accounting for most of that.

Nasal Cannula Market Size Forecast

Key Takeaways

Type Analysis

In 2023, the Low Flow Nasal Cannula segment held a dominant market position, capturing more than a 65% share. This dominance can be attributed to its widespread use in healthcare settings, particularly for patients requiring minimal oxygen support. Low-Flow Nasal Cannulas are preferred due to their ease of use, comfort, and cost-effectiveness, making them suitable for a wide range of patients, from neonates to the elderly. They are typically used in cases where patients need supplemental oxygen at a rate of 1-6 liters per minute, which accounts for a significant portion of the oxygen therapy market.

On the other hand, the High Flow Nasal Cannula segment, though smaller in market size, is rapidly gaining traction. This is primarily due to its ability to provide a higher flow of oxygen, up to 60 liters per minute, which is crucial for patients with more severe respiratory conditions. The High Flow Nasal Cannula is increasingly being recognized for its benefits in delivering heated, humidified oxygen, thus enhancing patient comfort and improving oxygenation. Its growing adoption in acute care settings, such as ICUs and emergency departments, reflects a trend towards more advanced respiratory support options.

Both segments are influenced by factors such as technological advancements, the increasing prevalence of respiratory diseases, and the aging global population. However, the specific growth trajectories and market dynamics of the Low Flow and High Flow Nasal Cannula segments are distinct, and shaped by their unique applications and patient requirements. As healthcare providers continue to seek optimal solutions for oxygen therapy, the evolution of these segments will likely be characterized by innovation and a deeper understanding of patient needs in respiratory care.

Material Analysis

In 2023, plastic nasal cannulas held a dominant market position, capturing more than an 85.3% share. This substantial market share can be primarily attributed to the cost-effectiveness and widespread availability of plastic cannulas. They are commonly used in various healthcare settings due to their affordability, which is particularly significant in markets with budget constraints. Plastic nasal cannulas are lightweight and generally comfortable for short-term use, making them a practical choice for a broad range of patients requiring oxygen therapy.

Silicone nasal cannulas, though occupying a smaller segment of the market, are gaining popularity for their enhanced comfort and durability. Silicone, being a softer and more flexible material, reduces the risk of skin irritation and pressure ulcers, especially in long-term care scenarios. This makes silicone cannulas a preferred option for patients requiring continuous oxygen therapy, such as those with chronic respiratory conditions. The higher cost of silicone cannulas is often justified by their longevity and patient comfort, appealing to a specific segment of the market focused on quality and patient experience.

Nasal Cannula Market Segmentation Analysis

End-use Analysis

In 2023, hospitals held a dominant position in the nasal cannula market, capturing more than a 44.9% share. This dominance is largely due to the critical role hospitals play in providing acute care and emergency services, where oxygen therapy is frequently required. Hospitals are equipped with a wide range of medical facilities and typically have a higher patient influx, thereby necessitating a large supply of nasal cannulas. The need for nasal cannulas in hospitals is further amplified by the rising incidence of respiratory illnesses and the growing number of surgeries requiring post-operative oxygen therapy.

Ambulatory healthcare services, while holding a smaller share, are an increasingly significant segment in the nasal cannula market. These services, which include outpatient care centers and day surgery centers, are becoming more prevalent due to their convenience and cost-effectiveness. As these centers handle a growing number of procedures and treatments that may require oxygen therapy, the demand for nasal cannulas in this segment is expected to rise.

Long-term care centers also represent a notable segment in the nasal cannula market. These centers cater to patients requiring extended care, including those with chronic respiratory conditions. The use of nasal cannulas in these settings is essential for providing long-term oxygen therapy, contributing to patient comfort and improved health outcomes.

The ‘Others’ category, encompassing various small-scale healthcare and home care settings, also forms a part of the nasal cannula market. This segment includes home healthcare services, which are gaining popularity due to the growing trend of at-home treatment for chronic diseases and the aging population.

Key Market Segments:

Based On Type

Based On Material

Based On End-use

Drivers

Restraints

Opportunities

Challenges

Trends

Regional Analysis

In 2023, North America is leading the nasal cannula market with a 42.3% share, amounting to USD 3.3 million. This dominance is primarily due to the rising incidence of respiratory diseases like COPD and asthma, which account for approximately 80% of healthcare spending on chronic diseases in the region. The presence of both local and international manufacturers has made advanced nasal cannulas more accessible and affordable, further driving market growth. For instance, in 2022, the U.S. alone generated over USD 2.9 billion in revenue from the nasal cannula market. One notable development was the launch of Luisa, an advanced ventilator by Movair in October 2021, which can switch between high-flow nasal cannula (HFNC) and non-invasive ventilation modes.

Asia Pacific is projected to be the fastest-growing region during the forecast period, spurred by the high prevalence of asthma and COPD, coupled with an aging population. The region’s market expansion is also supported by increasing healthcare spending and the rise of local manufacturers.

Nasal Cannula Market Regional Analysis

Key Regions and Countries

Key Players Analysis:

The global nasal cannula market is experiencing growth due to several key factors. The increasing number of respiratory diseases, a growing elderly population, and a surge in adoption are major contributors to this growth. The Covid-19 pandemic has particularly spiked the demand for nasal cannulas, prompting manufacturers to ramp up production.

This market is diverse with several leading players. Becton, Dickinson and Company are among the top companies dominating this space. These companies are continually innovating their products, expanding geographically, and forming partnerships to strengthen their market position. For example, high-flow nasal cannula (HFNC) therapy, recommended by institutions like the U.S. National Institutes of Health (NIH) and the World Health Organization (WHO) for certain COVID-19 patients, is an area of focus for these companies.

Маrkеt Кеу Рlауеrѕ:

Recent Developments

点赞 0
举报
收藏 0
评论 0
分享 0